현재 가격
$111.56
경쟁 해자
↑Strong Patent Protection on Key Drugs
Merck benefits from patents protecting drugs like Keytruda, creating pricing power and market exclusivity. This shields them from immediate generic competition, driving revenue.
↑Established Brand Reputation and Trust
Decades of research and development have built a strong brand. Doctors and patients trust Merck's products, leading to brand loyalty and market share.
↑Extensive Global Distribution Network
Merck's global reach allows efficient drug distribution. This infrastructure provides a competitive advantage, especially in emerging markets.
투자 리스크
↓Patent Expirations and Generic Competition
Loss of exclusivity on key drugs will significantly impact revenue. Generic versions erode market share and pricing power quickly.
↓R&D Pipeline Uncertainty and Failure
Drug development is inherently risky, with high failure rates. A lack of successful new drugs could hinder future growth and profitability.
↓Increasing Regulatory Scrutiny and Litigation
Pharmaceutical companies face intense regulatory oversight. Lawsuits and compliance issues can lead to significant financial penalties.
AI 인사이트를 DCF 또는 PE 주식 밸류에이션과 결합하여 내재가치를 계산하세요. 데이터에 기반한 더 나은 주식 밸류에이션 결정을 내리세요.
본 페이지는 Merck & Co., Inc. (MRK)에 대한 AI 기반 주식 밸류에이션 인사이트를 경쟁 해자와 투자 리스크 요인을 포함하여 제공합니다. 주식 밸류에이션은 건전한 투자 결정의 핵심입니다 — MiniValuator의 DCF 및 PE 주식 밸류에이션 도구를 이러한 AI 인사이트와 함께 사용하여 MRK의 내재가치, 안전마진을 계산하고 근거 있는 주식 밸류에이션 판단을 내리세요.
